Exogenous surfactant therapy for acute respiratory distress in infancy
✍ Scribed by M. Moreno; J. López-Herce; C. Merello; A. Alcaraz; A. Carrillo
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 116 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We conducted a prospective, randomized, controlled trial comparing the efficacy of two doses of a reconstituted bovine surfactant (Surfactant TA) in premature infants requiring mechanical ventilation shortly after birth for respiratory distress syndrome. Forty-six infants weighting 1000-1499 g were
Surfactant deficiency in newborn infants with hyaline membrane disease (HMD) reduces peripheral airway stability, leading to lung atelectasis, inhomogeneity of distribution of ventilation, ventilation/perfusion mismatch, and hypoxemia. The aim of this study was to evaluate the immediate effect of ex